Dongzhimen Hospital, Beijing
Clinical trials sponsored by Dongzhimen Hospital, Beijing, explained in plain language.
-
Herbal granule shows promise for stroke recovery in early trial
Disease control Not yet recruitingThis study tests a Chinese herbal medicine called Xinglou Chengqi Granule in 60 people who recently had an acute ischemic stroke. The goal is to find the best dose and see if it helps improve stroke symptoms and daily function. Participants will be monitored for up to 90 days to …
Phase: PHASE2 • Sponsor: Dongzhimen Hospital, Beijing • Aim: Disease control
Last updated May 26, 2026 05:32 UTC
-
Herbal capsule may slow brain vessel damage in hypertension patients
Disease control Not yet recruitingThis study tests whether Songling Xuemaikang capsules can help control cerebral small vessel disease (CSVD), a condition where tiny blood vessels in the brain get damaged over time, often linked to high blood pressure. Researchers will enroll 90 adults aged 55-75 with high blood …
Phase: NA • Sponsor: Dongzhimen Hospital, Beijing • Aim: Disease control
Last updated May 26, 2026 05:24 UTC